Jensen V - Search Results

1

A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.

Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J. Alsner J, et al. Among authors: jensen v. Acta Oncol. 2008;47(4):600-7. doi: 10.1080/02841860802047411. Acta Oncol. 2008. PMID: 18465328

2

Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.

Laurberg T, Alsner J, Tramm T, Jensen V, Lyngholm CD, Christiansen PM, Overgaard J. Laurberg T, et al. Among authors: jensen v. Acta Oncol. 2017 Jan;56(1):59-67. doi: 10.1080/0284186X.2016.1246803. Epub 2016 Nov 16. Acta Oncol. 2017. PMID: 27846764

3

Male breast cancer: a nation-wide population-based comparison with female breast cancer.

Lautrup MD, Thorup SS, Jensen V, Bokmand S, Haugaard K, Hoejris I, Jylling AB, Joernsgaard H, Lelkaitis G, Oldenburg MH, Qvamme GM, Soee K, Christiansen P. Lautrup MD, et al. Among authors: jensen v. Acta Oncol. 2018 May;57(5):613-621. doi: 10.1080/0284186X.2017.1418088. Epub 2017 Dec 23. Acta Oncol. 2018. PMID: 29276849

4

Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.

Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sørensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brünner N. Holten-Andersen MN, et al. Among authors: jensen v. Clin Cancer Res. 2002 Jan;8(1):156-64. Clin Cancer Res. 2002. PMID: 11801553

5

Prognostic comparison of three classifications for medullary carcinomas of the breast.

Jensen ML, Kiaer H, Andersen J, Jensen V, Melsen F. Jensen ML, et al. Among authors: jensen v. Histopathology. 1997 Jun;30(6):523-32. doi: 10.1046/j.1365-2559.1997.5720795.x. Histopathology. 1997. PMID: 9205856

6

Diabetes and Breast Cancer Subtypes.

Bronsveld HK, Jensen V, Vahl P, De Bruin ML, Cornelissen S, Sanders J, Auvinen A, Haukka J, Andersen M, Vestergaard P, Schmidt MK. Bronsveld HK, et al. Among authors: jensen v. PLoS One. 2017 Jan 11;12(1):e0170084. doi: 10.1371/journal.pone.0170084. eCollection 2017. PLoS One. 2017. PMID: 28076434 Free PMC article.

7

MIB-1 expression in breast carcinomas with medullary features. An immunohistological study including correlations with p53 and bcl-2.

Jensen V, Jensen ML, Kiaer H, Andersen J, Melsen F. Jensen V, et al. Among authors: jensen ml. Virchows Arch. 1997 Aug;431(2):125-30. doi: 10.1007/s004280050078. Virchows Arch. 1997. PMID: 9293894

8

Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts.

Ladekarl M, Jensen V. Ladekarl M, et al. Among authors: jensen v. Virchows Arch. 1995;427(3):265-70. doi: 10.1007/BF00203393. Virchows Arch. 1995. PMID: 7496595

9

Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.

Jensen V, Sørensen FB, Bentzen SM, Ladekarl M, Nielsen OS, Keller J, Jensen OM. Jensen V, et al. Among authors: jensen om. Histopathology. 1998 Jun;32(6):536-46. Histopathology. 1998. PMID: 9675593

10

The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer.

Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, Soerensen FB. Jensen V, et al. J Pathol. 1995 Aug;176(4):343-52. doi: 10.1002/path.1711760405. J Pathol. 1995. PMID: 7562249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

468 results

Search Page